Beckley Psytech Stock
Beckley Psytech is a clinical-stage biotechnology company developing psychedelic-based medicines for neuropsychiatric disorders. Its platform leverages scientific research and drug development expertise to deliver innovative treatments for conditions such as depression and anxiety.
Founded: 2019
For more Beckley Psytech stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Cosmo Feilding Mellen Chief Executive Officer |
| Dr. Rob Conley Chief Scientific and Medical Officer |
| Michael Norris Chief Financial Officer |
| Matt Hartley Chief Operating Officer |
